With Cyberattack Fix Weeks Away, Health Providers Slam Unitednews2024-03-08T23:58:28+00:00March 8th, 2024|The New York Times|
A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Marketnews2024-03-08T15:06:16+00:00March 8th, 2024|The New York Times|
F.D.A. Delays Action on Closely Watched Alzheimer’s Drugnews2024-03-08T11:45:07+00:00March 8th, 2024|The New York Times|
¿Se puede tener alzhéimer y no presentar síntomas?news2024-03-06T15:35:15+00:00March 6th, 2024|The New York Times|
Cyberattack Paralyzes the Largest US Health Care Payment Systemnews2024-03-05T22:37:45+00:00March 5th, 2024|The New York Times|
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapynews2024-03-05T18:32:51+00:00March 5th, 2024|The New York Times|
What to Know About Ibogaine, a Psychedelicnews2024-03-05T08:00:07+00:00March 5th, 2024|The New York Times|
Opill, an Over-the-Counter Birth Control Pill, Will Be Available Soonnews2024-03-04T22:59:02+00:00March 4th, 2024|The New York Times|
Apparently Healthy, but Diagnosed With Alzheimer’s?news2024-03-04T17:25:50+00:00March 4th, 2024|The New York Times|
